U.S. Markets closed

STADA Arzneimittel Aktiengesellschaft (SAZ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
78.00+1.29 (+1.68%)
At close: 5:38PM CEST
Full screen
Previous Close76.71
Open76.55
Bid0.00 x 5000
Ask0.00 x 28500
Day's Range75.68 - 78.00
52 Week Range41.41 - 78.00
Volume1,010,906
Avg. Volume489,101
Market Cap4.85B
BetaN/A
PE Ratio (TTM)46.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • STADA Arzneimittel AG – Value Analysis (XETRA:SAZ) : August 21, 2017
    Capital Cube2 days ago

    STADA Arzneimittel AG – Value Analysis (XETRA:SAZ) : August 21, 2017

    Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives STADA Arzneimittel AG a score of 38. Our analysis is based on comparing STADA Arzneimittel AG with the following peers – Biotest AG Pref, Merck KGaA, Chemical Works of Gedeon Richter Plc, Bayer AG and MorphoSys AG (BIO3-DE, MRK-DE, RIG2-DE, BAYN-DE and MOR-DE). Investment Outlook STADA Arzneimittel ... Read more (Read more...)

  • STADA Arzneimittel AG breached its 50 day moving average in a Bullish Manner : SAZ-DE : August 21, 2017
    Capital Cube3 days ago

    STADA Arzneimittel AG breached its 50 day moving average in a Bullish Manner : SAZ-DE : August 21, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for STADA Arzneimittel AG. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Financial Times6 days ago

    [$$] Cinven and Bain secure Stada for ?4.1bn after second push

    Private equity groups Cinven and Bain Capital have agreed the largest leveraged buyout of a European-listed company in four years with a ?4.1bn deal to acquire Stada, the German generic drugmaker. The ...